ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology. The company has an active pipeline of six drugs and one medical device (ABV-1701/Vitargus®) under development, utilizing in-licensed technology from its network of world-renowned research institutions to conduct proof-of-concept trials through Phase II of clinical development.